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Abstract
Purpose: The aim of this review was to identify patient reported outcome measures (PROMs) for use in research
and clinical practice involving individuals with visual impairment following stroke and to evaluate their content
validity against quality assessment criteria.
Method: A systematic review of the literature was conducted to identify articles related to the development and/or
validation of PROMS. We searched scholarly online resources and hand searched journals. Search terms included
MESH terms and alternatives relating to PROMs, visual impairments and quality of life. Data were extracted relating
to the development and validation of the included instruments. The quality of the development process was
assessed using a modified version of a PROM quality assessment tool.
Results: A total of 142 PROMs were identified, 34 vision-specific PROMs were relevant and available to be analysed
in this review. Quality appraisal identified four highly rated instruments: the National Eye Institute Visual Functional
Questionnaire (NEI-VFQ), Activity Inventory (AI), Daily Living Tasks Dependant on Vision (DLTV) and Veterans Affairs
Low Visual Function Questionnaire (VA LV VFQ). The four instruments have only been used with either a limited
number of stroke survivors or a sub-population within visual impairment following stroke.
Conclusion: No instruments were identified which specifically targeted individuals with visual impairment following
stroke. Further research is required to identify the items which a population of stroke survivors with visual impairment
consider to be of most importance. The validation of a combination of instruments or a new instrument for use with
this population is required.
Introduction
Approximately 152,000 people experience a stroke every
year in the UK [1]. The numbers who experience visual
problems as a consequence of stroke are not yet accur-
ately known. An estimate of prevalence of post-stroke
visual impairment has been reported at around 60 % [2].
There are a wide variety of visual problems which can
result from stroke: visual field loss, ocular motility de-
fects, visual inattention, reduced visual acuity and visual
perception problems [3–6]. It is possible for a visual
problem to occur from a stroke lesion in any area of the
brain [7]. Visual impairments have been shown to limit
daily activities and independence, contributing to de-
pression and reduced motivation [8, 9].
A patient reported outcome measure (PROM) “ad-
dresses some aspect of the patient’s subjective experi-
ence of health and the consequences of illness” [10].
These measures can capture an individual’s functionality
and feelings related to either their general health or a
specific condition. Using self-reporting allows PROMs to
capture concepts which would not be possible by any
other method [11]. PROMs are used for a wide range of
purposes, from establishing the impact of a condition on
an individual, assessing the effectiveness of a method of
treatment, and as a utility index [12].
Different types of instruments exist, ranging from gen-
eric, to disease-specific, to individualised instruments
[10]. Generic instruments do not focus on a particular
condition, and therefore can be applied to a wide range
of population groups as they are broad in scope, e.g.
Euro-QoL (EQ-5D), Short Form Health Survey (SF-12)
[13, 14]. Disease-specific instruments are tailored to the
condition of interest and are more likely to contain
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items relevant to that disease, e.g. Asthma Quality of
Life Questionnaire (AQLQ), Child Amblyopia Treatment
Questionnaire (CAT-QoL) [15, 16]. Individualised in-
struments allow the individual to select the items which
are of most importance to them. Firstly, individuals are
asked to rank tasks of importance to their lives, then
subsequently the effect of their health condition on
those specific tasks. e.g. Patient Generated Index (PGI),
Schedule for the Evaluation of Individual Quality of Life
(SEIQoL) [17, 18]. It is possible for PROMs to cover
more than one of these types.
Literature reviews of PROMs for ocular conditions
causing visual impairment, such as glaucoma and cata-
ract, have been conducted, some of which give recom-
mendations for which instrument to use for different
disease specific populations [19–22].
NHS services are increasingly being asked to provide
evidence of the impact of their care [23]. One method of
achieving this objective is by asking individuals to
complete a PROM. For example, since 2009, data has
been collected nationally in England, before and after
four commonly performed elective surgical procedures
(hip replacements, knee replacements, varicose vein and
groin hernia surgery) using PROMs [12].
The aim of this review was to identify PROMs avail-
able for use in research and clinical practice involving
individuals with visual impairment following stroke, and
to evaluate their content validity against quality assess-
ment criteria. This review will focus on high quality in-
struments which have previously been validated with
stroke survivors. A secondary aim is to highlight suitable
high quality alternative instruments which have not yet
been validated for stroke survivors.
Methods
Search strategy
A systematic search strategy was used to search the fol-
lowing key electronic databases: MEDLINE (1948 to
August 2014), SCOPUS (1823 to August 2014), AMED
(1985 to August 2014), CINAHL (1937 to August 2014)
and PsycINFO (1887 to August 2014). Citation tracking
was performed using Web of Science Cited Reference
Search for all included studies, and reference lists of in-
cluded articles were searched. Search terms included a
variety of MESH terms and alternatives in relation to pa-
tient reported outcome measures, visual impairments and
quality of life (Table 1).
Inclusion and exclusion criteria
Articles related to the development and/or validation of
PROMs for adult stroke survivors were included. Arti-
cles related to ocular stroke (central and branch retinal
artery occlusion) were deemed to be outside the scope
of this review and were therefore excluded. Some of the
visual problems experienced following a stroke are also
experienced by other population groups, for example
visual field loss is also experienced with glaucoma and
blurred reduced vision is experienced with cataracts.
Therefore, articles related to the development and/or
validation of PROMs for individuals with visual impair-
ment which could be experienced following other ocular
conditions were also included. Studies evaluating ques-
tionnaires in languages other than English were excluded,
unless the questionnaire was originally developed in an-
other language and later translated to English. PROMs
which were not accessible, for example if they required
payment to view, were excluded.
Table 1 Search terms
Eye/
Eye Disease/
Eye Abnormalities
Vision, Ocular/
Vision Disorders/
Visually Impaired Persons/
Blindness/
Vision, Low/
Visual Acuity/
Eye Movements/
Diplopia/
Ocular Motility Disorders/
Strabismus/
Vision, Binocular/
Vision, Monocular/
Nystagmus, Pathologic/ 
Visual Fields/
Visual Perception/
“Quality of Life”/
“Value of Life”/
“Activities of Daily Living”/
daily life activity
rating scale
Questionnaires/
visual function questionnaire
vision related quality of life
visual function
questionnaire studies 
Psychometrics/
Rasch analysis/
Validation Studies/
validation
item response theory
reliability
validity
development 
OR OR OR
AND
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Selection of studies
The titles and abstracts identified from the search were
screened using the pre-stated inclusion criteria. The full
papers of any studies considered potentially relevant
were then considered and the selection criteria applied.
Quality assessment
All included PROMs were quality assessed using a modi-
fied version of a published quality assessment tool [20,
24]. The modified quality assessment tool is shown in
Table 2. The tool is made up of two parts, the first eval-
uates the development of the instrument and the second
evaluates the performance of the instrument in terms of
validity and reliability [24]. For the purposes of this re-
view, six items from part one were relevant, focusing on
evaluating the development of the instrument. For each
of the quality assessment items the instruments were
judged against specific criteria to have a positive rating
(√√), a minimal acceptable rating (√) or a negative rating
(X), and if information relating to the criteria was not
reported ‘NR’ was recorded [24]. The quality assessment
focused on the robustness of the methodology of devel-
opment rather than the reliability and validity of the in-
struments. The validity in the target population does not
necessarily translate to the instrument being valid or ap-
propriate to a stroke population.
Data synthesis
A descriptive analysis table (Additional file 1) was com-
pleted from the included articles with the following data:
initial aim of the PROM, the intended population, how
items were identified, whether stroke survivors were part
of the development process, the process for selecting
items included in the instrument and the scale, the val-
idation processes including populations for which the in-
strument has been validated. The quality assessment
data was synthesised using a graphical representation for
each ratings into a table (Table 3).
Results
The search revealed 142 PROMs of which 43 vision-
specific PROM instruments were identified as being
Table 2 Quality assessment tool for evaluation of PROMs modified from Pesudovs et al. [24] and Hamzah et al. [20]
Quality criteria Definition Quality criteria
Pre-study hypothesis The pre-study specification of the aim of the
instrument and the intended population
√√ A clear description is provided of the aim of the instrument and
the intended population
√ Only one of the above
X Neither reported
Intended population The extent to which the instrument has been
studied in the intended population
√√ Intended population studied
√ Partly studied only or sample size was small (less than 50 patients)
X Not studied in the intended population, only generic
Actual content area The extent to which the content meets the
pre-study hypothesis specifications
√√ Content is intended and is relevant to the intended population
√ Some of the intended content areas are missing
X Content areas are not relevant to the intended population
Item identification Selection of the items relevant to the target
population for inclusion in the pilot instrument
√√ Comprehensive consulting with patients (focus groups or in-depth
interviews) and a literature review
√ Minimal consultation with patients and expert opinion and
literature review
X No consultation with patients
Item selection Determining the items included in the final
instrument
√√ A pilot instrument was developed and tested with Rasch or factor
analysis and statistical justification provided for removing items, plus
items with floor and ceiling effects removed and the amount of missing
data considered
√ Only one of the above techniques were used
X No pilot instrument OR no statistical justification of items included
in the final instrument
Scoring A description of how the instrument should
be scored
√√ Rasch scoring of a statistically justified response scale
√ Summary scoring of a statistically justified response scale
X Scoring system not described or scoring of a statistically unjustified
or faulty scale
If not reported, scored as ‘NR’; √√ positive rating; √ minimal acceptable rating; X negative rating
Hepworth et al. Health and Quality of Life Outcomes  (2015) 13:146 Page 3 of 10
Table 3 Results of the quality appraisal of the content validity of the included instruments
Instrument Pre-study 
hypothesis
Intended 
population
Actual 
content area
Item 
identification
Item 
selection
Scoring
Activities of daily vision scale (ADVS)
Activity Inventory (AI)
Adaptation to age-related vision loss scale 
(AVL)
Adult Strabismus Quality of Life 
questionnaire (AS-20)
Amblyopia and strabismus questionnaire 
(ASQE)
Catquest
Daily living tasks dependent on vision  
(DLTV)
Diplopia questionnaire
Glaucoma quality of life -15 questionnaire 
(GQL-15)
Houston vision assessment test (HVAT)
Impact of vision impairment (IVI)
Indian visual function questionnaire 
(IND-VFQ)
Low vision quality of life questionnaire 
(LVQoL)
Melbourne low vision ADL index (MLVAI)
Mobility questionnaire
National Eye Institute Refractive Error  
Correction quality of life Questionnaire 
(NEI RQL) 
National Eye Institute Visual Functioning 
Questionnaire (NEI VFQ) and Long form 
visual functioning scale (LFVFS-39)
Nursing home vision targeted health 
related quality of life questionnaire 
(NHVQoL)
Quality of life and visual function 
questionnaire (QoL-VFQ)
Quality of vision (QoV)
Self-report assessment of functional visual 
performance 
(SRA-VFA) 
Severity of visual field damage 
Veterans affairs low vision visual 
functioning questionnaire 
(VA LV VFQ)
Vision and quality of life index (VisQoL)
Vision function and quality of life 
questionnaires
(VF and QOL) 
Vision related quality of life  (VQoL)
or
Vision-related quality of life core measure
(VCM1)
Visual activity questionnaire (VAQ)
Visual disability assessment  (VDA)
Visual disability questionnaire (VDQ)
Visual function index (VFI)
Visual functioning 14 items (VF-14)
Visual symptom and quality of life 
questionnaire (VSQ)
NR
If not reported, scored as ‘NR’; √√ positive rating; √ minimal acceptable rating; X negative rating
Gray color: Used with stroke patients
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relevant. However, nine of these instruments were ex-
cluded as they were not accessible. Lack of accessibility
was due to requiring payment or no development or val-
idation papers could be found for an instrument. A total
of 34 vision-specific PROMs were analysed for this re-
view. Specific details of all PROMs included are shown
in Additional file 1.
Target condition
None of the instruments reviewed had been specifically
targeted at visual impairment following stroke. Eighteen
of the instruments were developed for populations with
visual impairment with no specific condition targeted.
As this group of instruments were aimed generally at
visual impairment, it was difficult to establish if stroke
survivors were included in the populations recruited by
studies reporting the use of these instruments. Of the
remaining instruments, eight were cataract-specific, three
were strabismus/amblyopia-specific, two were glaucoma-
specific, two were retinal disease-specific and one was re-
fractive error-specific.
None of the PROMs included in the review sought the
views of stroke survivors during the item identification
process. The Neuro-10 supplement was created to adapt
the National Eye Institute Visual Functional Questionnaire
(NEI-VFQ) to be better targeted to a population experien-
cing visual impairment due to neuro-ophthalmic disorders
[25]. Of note, however, is the item identification process of
the Neuro-10 supplement only involved individuals with
multiple sclerosis.
Administration
The methods of administration varied between inter-
view, self-administration and a combination of both.
Details of the administration methods used by each instru-
ment are outlined in Additional file 1. A study into the
most appropriate method of administration of vision-
related quality of life instruments concluded postal admin-
istration to be the most reliable, valid and cost-effective
[26]. However, depending on the severity of visual impair-
ment it may not be possible for an individual to complete
a self-administration of an instrument [27]. It is important
to consider the method which best suits the population
group and/or the individual [28].
Instrument content
The instruments had a broad range in the number of
items per instrument, the smallest being the Vision and
Quality of Life Index (VisQoL) with six items, and the
largest being the Activity Inventory (AI) with up to 337
items [29, 30]. The mean number of items was 39 (SD
57.7) across the instruments reviewed and the median
number of items was 25 (IQR 17 to 38).
Instrument development and quality
Instruments validated with stroke survivors
Content validity assesses if the instrument and individual
items are relevant to the target population and are able
to measure the area of interest [31]. A summary of the
descriptive analysis of the development and content val-
idity for each instrument is provided in Additional file 1
and the quality assessment is available in Table 3. Five
instruments were found to have been tested with stroke
survivors: NEI-VFQ (Neuro 10), AI, DLTV, (Daily Living
Tasks Dependant on Vision), VA LV VFQ (Veteran Af-
fairs Low Visual Function Questionnaire) and SRA-FVP
(Self-Reported Assessment of Functional Visual Per-
formance). In order to focus on the aim, the remainder
of this review will concentrate only on the analysis of
these instruments [25, 30, 32–35].
The instrument found to have the highest number of
positive ratings in the quality assessment was the NEI-
VFQ 25 (Neuro 10). The NEI-VFQ 25 is composed of 11
vision-related subscales: vision rating, near vision activ-
ities, distance vision activities, social functioning, role
limitation, dependency, mental health, driving, periph-
eral vision, colour vision and ocular pain with an add-
itional question for general health rating [32]. There is
also the option to add items to a specific sub-scale. The
instrument provides an overall composite score [36]. It
is unclear if any stroke survivors were involved in the
item identification of the NEI-VFQ 25 or Neuro 10 sup-
plement as the population had a variety of causes of vis-
ual impairment including neurological aetiologies. Five
studies (n = 608) have subsequently used this instrument
to assess quality of life in individuals with visual impair-
ment following stroke, especially in individuals with
homonymous hemianopia [9, 37].
Of the instruments previously used with a stroke
population two were ranked as joint second with regard
to quality assessment. These were the AI and the VA
LV VFQ. During the development stages of these in-
struments, stroke survivors were not involved in item
identification.
The validation process for the AI involved a popula-
tion with visual impairment due to a variety of aetiol-
ogies. This population included a small proportion (3 %)
with stroke or traumatic brain injury [38]. The AI uses a
theoretical framework called Activity Breakdown Struc-
ture to allow the questionnaire to be adapted for each
individual. At the highest level of this structure are three
‘objectives’: daily living, social interaction and recreation
[30]. Under these headings are 41 ‘goals’, for example
cooking a meal, which would be required to achieve the
‘objective’ of daily living. The ‘goals’ are then divided into
the specific ‘tasks’ of which there are 337, for example
reading a recipe, measuring ingredients and reading
oven dials, which must be achieved to successfully
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complete the ‘goal’. The importance of each ‘goal’ is ini-
tially rated by the individual, and if it is not considered
important, the next ‘goal’ is considered. If it is deemed
important the individual is asked to rate the difficulty of
the ‘tasks’ that make up that ‘goal’ [30]. The design of
this instrument allows the number of items to vary de-
pending on the number of goals important to the
individual.
The VA LV VFQ was originally validated with patients
with ophthalmic pathology such as glaucoma, macular
degeneration and diabetic retinopathy [34, 39, 40]. It
was later used with a small group (n = 24) of stroke sur-
vivors with homonymous hemianopia [41]. The VA LV
VFQ is composed of five domains: visual ability, reading,
mobility, visual motor and visual information. The in-
strument consists of a total of 48 items, with each item
made up of four questions: for example: “Is it difficult to
read menus?”. If the answer to the first question is yes, the
following questions are subsequently asked “Is it because
of your vision?”, “Do you want training to read menus?”
and finally “How do you usually read menus?” [40].
The instrument ranked next with regard to quality as-
sessment was the DLTV. The DLTV was originally devel-
oped for use with individuals with macular degeneration.
It was later used with a group of stroke survivors with vis-
ual impairment, the total population was large (n = 915),
however, only 63 participants were reported to have com-
pleted the questionnaire [42]. It comprises 24 items which
are not categorised under named domains, but covers
topics such as reading, mobility, self-care and recognition
[35]. Fifteen of the items use the following question “How
much difficulty do you have pouring yourself a drink”.
Two mobility questions use “How confident are you in
your ability to walk around in your immediate neighbour-
hood”. Five questions on reading use the following ques-
tion “With your near glasses on, how much difficulty do
you have reading normal sized newspaper print”. The final
two questions ask “How would you rate your overall dis-
tance and near vision” [35].
The other instrument which has previously been used
with stroke survivors is the SRA-VFP, however this use
was limited to individuals with homonymous hemian-
opia [33]. This instrument consists of 38 items covering
a range of activities of daily living: reading, clothing care,
meal preparation, leisure participation, financial man-
agement, shopping, writing, communication, health
management, social participation, functional mobility,
personal hygiene, feeding and dressing. The individual
completing the instrument is ask to rate their ability
to perform each task. This instrument scored a lower
rating on quality assessment than the NEI-VFQ (Neuro
10), AI, VA LV VFQ and DLTV, as patients were not con-
sulted in the item selection process it only involved expert
opinion.
Instruments not yet validated with stroke survivors
Of the other instruments not previously tested with
stroke survivor populations, a number achieved high
positive ratings and might be appropriate for use with a
specific visual condition or symptom arising due to
stroke. For instance the Diplopia questionnaire or the
Adult Strabismus Quality of Life questionnaire (AS-20)
could be used with stroke survivors experiencing ocular
motility problems [43, 44]. None of the high positive rat-
ing instruments in the quality assessment were found to
be specific for visual field loss. The instruments for spe-
cific visual conditions or symptoms (Diplopia question-
naire and AS-20) are unlikely to be suitable for use with
stroke populations experiencing varied and mixed visual
impairment post-stroke.
The AS-20 is comprised of 20 items originally divided
equally into two domains psychological and function.
The domains were later divided further into self-
perception, interactions, reading function and general
function [43, 45]. The questions are statements which
the individual is asked to record the frequency of
occurrence.
The Diplopia Questionnaire consists of eight items,
the first question is a filter question asking if diplopia
has been noticed in the past week. If yes, the following
items record the frequency of diplopia in seven positions
of gaze, simply asking if “During the last week, did you
have double vision when reading (in a normal reading
position” [44].
An alternative to using these instruments for specific
visual conditions is to use a vision-specific instrument
which has no target condition. Four such instruments
achieved the highest positive rating in quality assessment:
Impact of Vision Impairment (IVI), Quality of Vision
(QoV), Vision Related Quality of Life (VQoL) and Visual
Symptom and Quality of Life Questionnaire (VSQ)
[46–49].
The IVI consists of 28 items within six domains: emo-
tional reaction to vision loss, household care, personal
care, leisure and work, mobility and social and consumer
interactions. The question focuses on the last month
and the frequency of impairment, for example “In the
past month, how much has your eyesight interfered with
visiting friends or family” [50].
The QoV is made up of 30 items covering ten symp-
toms: glare, haloes, starbusts, hazy vision, blurred vision,
distortion, double vision, fluctuation, focusing difficul-
ties, and judging distances. The questions ask regarding
the frequency, severity and bothersomeness of each
symptom [49].
The VQoL is a parent questionnaire which can contain
up to 139 items, this instrument has a modular approach
to enable it to meet the requirements of different popu-
lation groups. The questions focus on the past month,
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for example “In the past month, how much has your
eyesight interfered with seeing food on the plate” or “In
the past month, how often have you felt anxiety because
of your eyesight” [48]. A core set of ten items were iden-
tified which became the VCM1. All items within the
VCM1 relate to emotional feelings and concerns, such
as embarrassment, frustration and worry [51]. There is
no method reported on how to decide if additional items
are required, but it is left flexible for the clinician or re-
searcher to decide dependant on the individual complet-
ing the questionnaire.
The VSQ has the option of either a long or a short
version. The long version consists of 26 items and the
short form is made up of 14 items, across two domains
symptoms/dysfunction and vision-specific quality of life.
There is no standard question wording, but examples in-
clude “When you are watching television, do you find it
difficult to see the picture clearly” and “How often does
your eyesight prevent you from doing the things you
would like to do” [46].
The IVI, VQoL and VSQ have been validated for use
with many different types of visual impairment, and
therefore may be suitable for use with a whole stroke
population [46, 48, 50–59].
Discussion
This review quality appraised existing vision-specific
PROMs to identify those which could be used for indi-
viduals with visual impairment following stroke. All in-
struments included in the review could potentially be
relevant for use when assessing the impact of visual im-
pairment following stroke, due to the wide variety of vis-
ual problems which may occur as a result of a stroke.
No instruments were clearly identified as involving
stroke survivors in item identification. As a consequence
none of the currently available instruments have been
influenced, during their development, by stroke survi-
vors. This limitation potentially results in instruments
having irrelevant items or not containing pertinent items
for the stroke population. Five instruments (AI, NEI-
VFQ, VA LV VFQ, DLTV and SRA-VFP) have been
administered with a stroke population embedded within
larger mixed population studies or a relatively small
sample [30, 32, 33, 41, 42]. The SRA-VFP is not dis-
cussed in detail in this review.
A stroke population has a wide variety of potential vis-
ual defects, for example ocular motility defects and vis-
ual perception defects. This instrument has not, to our
knowledge, been validated for the wider stroke popula-
tion. The NEI VFQ (Neuro 10) and VA LV VFQ, have
been used with stroke survivors, this use was restricted
to a subpopulation and if the instrument is to be used
with stroke survivors with all forms of visual impair-
ment, it requires further validation.
There are also problems with question phasing in the
AI and DLTV, they do not include a reference to vision
or eyesight, but simply “how difficult is it for you to walk
without assistance of another person?” or “how much
difficulty do you have cutting up food on your plate” re-
spectively [38, 60]. Stroke survivors commonly have
other new physical and cognitive deficits in addition to
visual impairment. It would not be clear from the AI
which deficit (visual/physical/cognitive) was causing, ei-
ther fully or partially, the difficulty experienced. Consid-
ering the limitation of these instruments it is advisable
that they should not be used for assessment of vision-
specific quality of life with stroke populations with visual
impairment.
The VA LV VFQ has the potential to include up to
192 questions depending on the number of goals the in-
dividual judges to be important, this is a high number
considering the individual completing the instrument
has visual impairment and potentially cognitive impair-
ment [40]. It is also well documented that the stroke
population are prone to fatigue [61]. Taking these factors
into account this instrument would not be the best fit
for a stroke population. The DLTV could be regarded as
being more suitable for completion by patients with re-
gard to the fewer number of items. This instrument has
previously been used with a population of stroke survi-
vors who had a wide range of visual impairments [62].
Some alternative instruments were identified during
the review. These were vision-specific instruments with
no target condition (IVI, QoV, VQoL and VSQ) with the
potential for use with stroke populations and other
instruments for specific visual impairments (AS-20 and
Diplopia questionnaire) following stroke. The IVI has
question phasing limitations similar to that of the AI
and DLTV, however, in this case some distinction can be
made at the extreme end of scoring ‘can’t do because of
eyesight’ ‘can’t do because of other reasons’. In cases
where the participant can do the activity but has a
degree of difficulty, it is not possible to identify if this is
due to visual impairment or other reasons. For this rea-
son this instrument would not be recommended for use
with a stroke population with visual impairment.
For the sub-population of stroke patients with ocular
motility defects, the AS-20 would be recommended over
the Diplopia questionnaire. The AS-20 assesses quality
of life, whereas, the Diplopia questionnaire establishes
the presence or absence of diplopia in different positions
of gaze.
It is important to acknowledge that none of these in-
struments have previously been validated for use within
a stroke population. The vision-specific instruments
without a target condition were of higher ranking in the
quality assessment than the specific visual impairment
instruments. If these were to be used for assessing
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vision-related quality of life in a stroke population, fur-
ther validation is recommended.
The quality assessment tool could be viewed as being
biased towards the use of Rasch analysis. However, there
has been a steady increase in the use of the Rasch model
within vision-specific quality of life measures over the
years. Many instruments which were conventionally de-
veloped have been re-engineered using the Rasch model
[63]. This is supported by 76 % of the instruments in-
cluded in this review have been evaluated using Rasch
analysis. Although conventional methods are still popu-
lar and summary scoring viewed as straightforward,
Rasch offers a robust measure of internal construct val-
idity and takes into account item difficulty by transform-
ing the ordinal scale to an interval scale [64].
Conclusion
In this review, no instruments were developed specific-
ally for visual impairment following stroke or involved
stroke survivors in the item identification phase of
instrument development. Five instruments have subse-
quently been used with stroke survivors. Four of these
instruments (AI, NEI-VFQ, DLTV and VA LV VFQ)
scored highly on positive ratings in the quality appraisal.
Three are vision-specific questionnaires and intended
for a broad population of individuals with visual impair-
ment. The exception is the DLTV which was originally
developed for individuals with macular degeneration.
Other instruments (IVI, QoV, VQoL and VSQ) were
identified in this review as having a potential application
with stroke survivors with visual impairment. Of the
instruments highlighted it is difficult without formal
testing to recommend which would be most appropriate
for use with a stroke population. However, the following
instruments, AI, DLTV, VA LV VFQ and IVI have been
highlighted as not be suitable for a stroke population
due to question phasing and response burden.
A combination of instruments may be required to
cover areas relevant to specific forms of visual impair-
ment which are important for the population of stroke
survivors with visual impairment. Further research is re-
quired to (a) consult a stroke population with different
forms of visual impairment with regard to the items that
they judge to be important and (b) to develop or validate
appropriate instruments for use with this population.
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